The present disclosure relates to an aerosol delivery device and a related method. The aerosol delivery device includes a heating chamber having an aerosol precursor composition disposed therein. A microwave radiation emitting device is operably engaged with the heating chamber and is configured to heat the aerosol precursor composition therein with the microwave radiation to form an aerosol from the aerosol precursor composition. An outlet port is formed in a housing of the aerosol delivery device and is in fluid communication with the heating chamber. The heating chamber is responsive to a suction applied to the outlet port for the aerosol to be drawn through the outlet port outwardly from the housing.

A convenient and hygienic skin therapy system comprising an encaser, one or more therapeutic compositions, a sealing means and optional accessories is disclosed. A method of using such a skin therapy system is also provided. The skin therapy system and the use thereof provides an effective, efficient and safe therapeutic approach.

The present disclosure relates to an aerosol delivery device and a related method. The aerosol delivery device includes a heating chamber having an aerosol precursor composition disposed therein. A microwave radiation emitting device is operably engaged with the heating chamber and is configured to heat the aerosol precursor composition therein with the microwave radiation to form an aerosol from the aerosol precursor composition. An outlet port is formed in a housing of the aerosol delivery device and is in fluid communication with the heating chamber. The heating chamber is responsive to a suction applied to the outlet port for the aerosol to be drawn through the outlet port outwardly from the housing.

A medical device system. The system includes a first medical device, a first remote interface, and a second remote interface in communication with the first remote interface and the first medical device, wherein the first medical device sends a command to the first medical device through the second remote interface, and wherein when the second remote interface receives the command, the command must be confirmed by the second remote interface before the command is send by the second remote interface to the first medical device.

A cartridge holds a perishable dielectric load, e.g. blood plasma, during heating n a heating chamber by means of an electromagnetic field from an emitting element. A conducting container of the cartridge is arranged between the emitting element and the perishable dielectric load. The conducting container holds dielectric matter and is arranged in contact with a load container for the perishable dielectric load, so that energy from the electromagnetic field is bridged into the perishable dielectric load. A first surface of the cartridge faces the emitting element and contains a recess for receiving any fluid having leaked out from the conducting container and/or the load container. A transmitter module for generating the electromagnetic energy repeatedly measures an impedance of the perishable dielectric load and the conducting container. If, due to any fluid being located in the recess, the impedance deviates substantially from a previous measurement, an alarm signal is generated.

The present disclosure relates to an aerosol delivery device and a related method. The aerosol delivery device includes a heating chamber having an aerosol precursor composition disposed therein. A microwave radiation emitting device is operably engaged with the heating chamber and is configured to heat the aerosol precursor composition therein with the microwave radiation to form an aerosol from the aerosol precursor composition. An outlet port is formed in a housing of the aerosol delivery device and is in fluid communication with the heating chamber. The heating chamber is responsive to a suction applied to the outlet port for the aerosol to be drawn through the outlet port outwardly from the housing.

Provided herein are methods of nerve blockage, for example for treatment of obesity, heart failure, cardiovascular disease, muscle spasms, chronic pain, or urinary retention in a patient. The method comprises first heating a nerve above physiological temperature (e.g. 37 C. in a human), such as from 43 C. to 54 C. for a duration that leads to reversible nerve blockage as opposed to nerve damage. Second, reversible nerve blockage is produced by cooling the nerve below physiological temperature to a temperature in which reversible nerve blockage is achieved, for example from 15 C. to 30 C.

Systems for expressing milk from a human breast are provided herein. Such systems can include a compression device having multiple fingers configured to at least partially surround a breast and apply pressure to a major portion of a breast without applying pressure to a remainder portion, thereby activating milk ducts within the breast. The fingers can be configured to apply pressure to an inferior portion and one or more lateral portions of the breast, without applying direct pressure to a superior portion. The fingers can be configured to apply pressure to a superior portion and one or more lateral portions of the breast, without applying direct pressure to an inferior portion. The fingers of the compression device can be configured to apply pressure to a superior portion, an inferior portion, and a first lateral portion of the breast, without applying direct pressure to a second lateral portion of the breast.

The present disclosure relates to an aerosol delivery device and a related method. The aerosol delivery device includes a heating chamber having an aerosol precursor composition disposed therein. A microwave radiation emitting device is operably engaged with the heating chamber and is configured to heat the aerosol precursor composition therein with the microwave radiation to form an aerosol from the aerosol precursor composition. An outlet port is formed in a housing of the aerosol delivery device and is in fluid communication with the heating chamber. The heating chamber is responsive to a suction applied to the outlet port for the aerosol to be drawn through the outlet port outwardly from the housing.

An aerosol-forming device may include a heater configured to dielectrically heat a solid aerosol-forming substrate by exposure to an RF electric field. The heater may include (i) an RF voltage source and (ii) a first and second electrode interconnected to the RF voltage source to generate an RF electric field between a heating area defined between the first and second electrodes. The heating area may be configured to removably accommodate a cylindrical sample comprising a solid aerosol-forming substrate. The first and second electrodes may each form concave surfaces and oppose each other.